entity

PARK

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about PARK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
30Hypotheses
2Analyses
0Outgoing
1Incoming
2Experiments
2Debates

No AI portrait yet

Wiki Pages (20)

Knowledge base pages for this entity

UCHL1 (PARK5) Pathway in Parkinson's Disease

mechanism · 3394 words

PARK7 — Parkinsonism Associated Deglycase (DJ-1)

gene · 3060 words

FBXO7 Protein (PARK15)

protein · 2779 words

ATP13A2 (PARK9) Pathway in Parkinson's Disease

mechanism · 2534 words

PARK2 - Parkin

gene · 2524 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (1)

SourceRelationTypeStr
MIR-146Aassociated_withmirna0.80

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
PINK1/Parkin mitophagy failure across PD, AD, and ALS 0.796 multi Cross-disease neurodegeneration mechanis
LRRK2 G2019S Kinase Inhibition for Parkinson's Disease 0.795 neurodegeneration Test
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A 0.790 neurodegeneration epigenetic reprogramming aging neurons
PINK1/Parkin–TREM2 Axis: Convergent Mitophagy Failure Unifie 0.780 neurodegeneration -
GBA1/GCase restoration to reduce alpha-synuclein pathology i 0.760 neurodegeneration Test
GBA1-Deficiency Disrupts Mitochondrial- Lysosomal Contact Si 0.747 neurodegeneration -
LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein 0.745 neurodegeneration Test
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK 0.738 alzheimers Cell type vulnerability in Alzheimers Di
NLRP3 Inflammasome Inhibition for Neuroprotection in Parkins 0.720 neurodegeneration Test
Pharmacologic activation of GBA1 to reduce alpha-synuclein b 0.720 neurodegeneration Test
LRRK2 kinase inhibition to normalize lysosomal trafficking i 0.710 neurodegeneration Test
Dasatinib plus Quercetin Senolytic Clearance of p16Ink4a-Hig 0.680 neurodegeneration -
OPTN/TBK1 mutations create selective vulnerability by blocki 0.670 neurodegeneration What are the neuron-specific effects of
Mitophagy and NAD pathway enhancement in sporadic Parkinson' 0.670 neurodegeneration Test
Alpha-synuclein phosphorylation-dominated LLPS hijacks synap 0.657 parkinsons -
LRRK2 Haploinsufficiency Traps Microglia in Senescence-Like 0.650 parkinsons -
Chronic ISR Activation Represses Axonal Protein Synthesis in 0.650 parkinsons -
PINK1/Parkin-pathway mitophagy impairment in sporadic Parkin 0.630 neurodegeneration Test
Dose-Response Framework: PINK1/Parkin Mitophagy as the Criti 0.614 neurodegeneration What are the optimal oxygen pressure, du
Age-Accelerated miR-155 Upregulation Primes Nigral Microglia 0.610 neuroinflammation How do regional, age, and sex-dependent
Exosomal α-Synuclein as an Interneuronal Propagation Vector 0.595 neurodegeneration Legacy Pre-Pipeline Hypothesis Import
Mitophagy Induction as Neuroprotective Strategy in Sporadic 0.585 neurodegeneration Legacy Pre-Pipeline Hypothesis Import
PINK1/PARK2-Mediated Mitophagy Enhancement for Neuroinflamma 0.571 neuroinflammation Immune atlas neuroinflammation analysis
TRPML1-PINK1/Parkin Axis Coordinates Mitophagy with Lysosoma 0.560 neurodegeneration Does TRPML1 enhancement cause therapeuti
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor 0.529 neurodegeneration Mitochondrial transfer between neurons a
Mitochondrial-Targeted PINK1/Parkin Pathway Activation for N 0.500 neurodegeneration Test Hypothesis Fixtures
Selectively Inhibit Maladaptive AQP4-Driven Astrocyte-Microg 0.500 neurodegeneration How can AQP4 be effectively targeted the
PINK1/PARK2-LC3 Mitophagy Enhancement 0.485 neuroinflammation Immune atlas neuroinflammation analysis
USP13 Stabilization of PINK1/Parkin Mitophagy in Parkinson's 0.393 neurodegeneration Test
TFEB Activation to Restore Lysosomal Function in Parkinson's 0.380 proteomics Quantitative proteomics of the aging syn

Mentioning Analyses (2)

Scientific analyses that reference this entity

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or c

neurodegeneration | 2026-04-11 | 0 hypotheses

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or e

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (2)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
Epigenetic clocks association with brain aging patterns in older women exploratory cognitive impairment and demen 0.900 0.00 human patients proposed N/A
iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD exploratory Parkinson's disease 0.900 0.00 iPSC-derived dopaminergic neur proposed N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Transcriptomic cytoarchitecture reveals principles of human neocortex organizati [PMID:37824655] Jorstad NL, Close J, Johansen N, Yanny A Science 2023 186
Targeted nanovesicular delivery of dexmedetomidine modulates microglial lysosoma [PMID:41778730] Zhang Y, Jiang H, Zhang F, Liao J Neural regeneration research 2026 0
The myocardial ischemic cascade network and multi-target synergistic interventio [PMID:41544859] Qi L, Yi J, Shen Y, Jiang H, Yao X et al Biochem Pharmacol 2026 0
Homoplantaginin ameliorates osteoarthritis by activating Sirt3/PINK1/Parkin sign [PMID:41720004] Zhang H, Xiao J, Yi Y, Chen B, Lv W et a Phytomedicine 2026 0
Kakkalide promotes spinal cord injury repair by regulating microglial M2 polariz [PMID:41720005] You T, Dai B, Ding X, He Z, Peng J et al Phytomedicine 2026 0
Interaction of mtROS-Immune-Inflammatory Vicious Cycle Activation in Sepsis-Indu [PMID:41905969] Wang Y, Yuan Q Clin Exp Pharmacol Physiol 2026 0
Metformin attenuates HSV-1-induced neuropathic pain by restoring Sirt3-mediated [PMID:41896899] Yuanyuan Fang; Mengqiu Deng; Kesheng Hua Cell communication and signali 2026 0
Hydrogen-Enriched Hyaluronic Acid Dressing Ameliorates Diabetic Foot Ulcer via P [PMID:41906653] Xu Z, Cui X, Chu H, Wan H, Xie Y, Wang Y Journal of diabetes 2026 0
Inhibition of mitochondrial ROS turns LC3-associated phagocytosis to autophagy u [PMID:41896101] Cheng YL, Su MS, Liao CC, Chang TW, Hsie Journal of microbiology, immun 2026 0
Hyperoside stabilizes ACAT1 to promote fatty acid oxidation and attenuate kidney [PMID:41903436] Shan C, Szili-Torok T, Yue G, Zhang L, M Phytomedicine : international 2026 0
Melatonin Ameliorates decaBDE-Induced Autism-Relevant Behaviors Through Promotin [PMID:41897550] ["Gao L", "Shen J", "Gao J", "Li T", "Ya Antioxidants (Basel, Switzerla 2026 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Isoginkgetin antagonizes ALS pathologies in its animal and patient iPSC models v [PMID:41094045] Li A, Huang S, Cao SQ, Lin J, Zhao L, Yu EMBO molecular medicine 2025 0
Sirtuins as mediators and targets of arsenic toxicity: unraveling signaling path [PMID:40844627] El-Mahrouk SR, El-Kadi AOS Archives of toxicology 2025 0
Targeted activation of ErbB4 receptor ameliorates neuronal deficits and neuroinf [PMID:40089796] Liu C, Zhao Y, Zhang W, Dao JJ, Li Q, Hu Journal of neuroinflammation 2025 0
Phenylpropanoids of Eleutherococcus senticosus (Rupr. & maxim.) maxim. Alleviate [PMID:40081261] Yang R, Meng X, Zhao W, Xu SQ, Wang SY, Bioorganic chemistry 2025 0
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] ["Chen Kai", "Li Fuyao", "Zhang Shuwen", Journal of neuroinflammation 2025 0
Small molecule DDQ involvement of ERK-mediated signaling pathway with enhanced m [PMID:40222458] Pradeepkiran JA, Kshirsagar S, Alvir RV, Biochimica et biophysica acta. 2025 0
The effects of Honokiol on the liver of Alzheimer's disease mice by upregulating [PMID:40776632] Wang H, Liu J, Tian YR, Zhu F, Li H Journal of Alzheimer's disease 2025 0
Publisher Correction: Age and sex affect deep learning prediction of cardiometab [PMID:33414494] Gerrits, Elen, Van Craenendonck, Trianta Scientific Reports 2021 0

Debates (2)

Multi-agent debates referencing this entity

The debate revealed a critical gap: while PINK1/PARKIN deficiency correlates wit

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The debate revealed a critical gap: while excitatory neurons show mitochondrial

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

Related Research

Hypotheses and analyses mentioning PARK in their description or question text

LAMP2A-Mediated Autophagy Enhancement Blocks Alpha-Synuclein Propagation in Park

Score: 0.745 · neurodegeneration · 2026-05-10

AAV9-mediated overexpression of LAMP2A enhances chaperone-mediated autophagy to selectively degrade pathological alpha-s

SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK1/Parkin Mitophagy D

Score: 0.738 · alzheimers · 2026-04-02

## Mechanistic Overview SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK1/Parkin Mitophagy Dysfunction start

NLRP3 Inflammasome Inhibition for Neuroprotection in Parkinson's Disease

Score: 0.720 · neurodegeneration · 2026-04-28

Targeted inhibition of NLRP3 inflammasome activation attenuates alpha-synuclein-driven microglial neuroinflammation, red

Pharmacologic activation of GBA1 to reduce alpha-synuclein burden in Parkinson's

Score: 0.720 · neurodegeneration · 2026-05-01

GBA1 mutations represent the strongest genetic risk factor for PD (OR 5-20x), and GCase dysfunction creates a druggable

LRRK2 kinase inhibition to normalize lysosomal trafficking in Parkinson's diseas

Score: 0.710 · neurodegeneration · 2026-05-01

LRRK2 G2019S mutations cause autosomal dominant PD through hyperactivation that impairs vesicular trafficking via Rab GT

OPTN/TBK1 mutations create selective vulnerability by blocking PINK1-Parkin-inde

Score: 0.670 · neurodegeneration · 2026-04-21

## Mechanistic Overview OPTN/TBK1 mutations create selective vulnerability by blocking PINK1-Parkin-independent mitophag

Mitophagy and NAD pathway enhancement in sporadic Parkinson's disease

Score: 0.670 · neurodegeneration · 2026-04-29

Sporadic Parkinson's disease may involve impaired mitochondrial quality control, and NAD augmentation or other mitophagy

PINK1/Parkin-pathway mitophagy impairment in sporadic Parkinson's disease

Score: 0.630 · neurodegeneration · 2026-04-30

Sporadic PD may include impaired mitochondrial quality control, reduced mitophagy flux, and dopaminergic vulnerability o

Dose-Response Framework: PINK1/Parkin Mitophagy as the Critical Mediator Linking

Score: 0.614 · neurodegeneration · 2026-04-17

## Mechanistic Overview Dose-Response Framework: PINK1/Parkin Mitophagy as the Critical Mediator Linking HBOT Parameters

Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Dis

Score: 0.610 · neuroinflammation · 2026-04-22

## Mechanistic Overview Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Disease Pathology s